223 related articles for article (PubMed ID: 32720120)
1. Ketogenic Diet for Malignant Gliomas: a Review.
Thomas JG; Veznedaroglu E
Curr Nutr Rep; 2020 Sep; 9(3):258-263. PubMed ID: 32720120
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies.
Noorlag L; De Vos FY; Kok A; Broekman MLD; Seute T; Robe PA; Snijders TJ
Clin Nutr; 2019 Oct; 38(5):1986-1994. PubMed ID: 30473444
[TBL] [Abstract][Full Text] [Related]
3. The ketogenic diet for the treatment of malignant glioma.
Woolf EC; Scheck AC
J Lipid Res; 2015 Jan; 56(1):5-10. PubMed ID: 24503133
[TBL] [Abstract][Full Text] [Related]
4. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth.
De Feyter HM; Behar KL; Rao JU; Madden-Hennessey K; Ip KL; Hyder F; Drewes LR; Geschwind JF; de Graaf RA; Rothman DL
Neuro Oncol; 2016 Aug; 18(8):1079-87. PubMed ID: 27142056
[TBL] [Abstract][Full Text] [Related]
5. Role of ketogenic metabolic therapy in malignant glioma: A systematic review.
Winter SF; Loebel F; Dietrich J
Crit Rev Oncol Hematol; 2017 Apr; 112():41-58. PubMed ID: 28325264
[TBL] [Abstract][Full Text] [Related]
6. Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients.
Klement RJ; Bandyopadhyay PS; Champ CE; Walach H
Theor Biol Med Model; 2018 Aug; 15(1):12. PubMed ID: 30122157
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma.
Schreck KC; Hsu FC; Berrington A; Henry-Barron B; Vizthum D; Blair L; Kossoff EH; Easter L; Whitlow CT; Barker PB; Cervenka MC; Blakeley JO; Strowd RE
Neurology; 2021 Aug; 97(9):e953-e963. PubMed ID: 34233941
[TBL] [Abstract][Full Text] [Related]
8. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.
Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W
J Neurooncol; 2014 Mar; 117(1):125-31. PubMed ID: 24442482
[TBL] [Abstract][Full Text] [Related]
9. The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service.
Martin-McGill KJ; Marson AG; Tudur Smith C; Jenkinson MD
Nutr Cancer; 2018; 70(4):643-649. PubMed ID: 29668317
[TBL] [Abstract][Full Text] [Related]
10. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
12. The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review.
Martin-McGill KJ; Srikandarajah N; Marson AG; Tudur Smith C; Jenkinson MD
CNS Oncol; 2018 Apr; 7(2):CNS17. PubMed ID: 29658772
[TBL] [Abstract][Full Text] [Related]
13. Effect of ketogenic diets on leukocyte counts in patients with epilepsy.
Schreck KC; Lwin M; Strowd RE; Henry-Barron BJ; Blakeley JO; Cervenka MC
Nutr Neurosci; 2019 Jul; 22(7):522-527. PubMed ID: 29254457
[TBL] [Abstract][Full Text] [Related]
14. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study.
Martin-McGill KJ; Marson AG; Tudur Smith C; Young B; Mills SJ; Cherry MG; Jenkinson MD
J Neurooncol; 2020 Mar; 147(1):213-227. PubMed ID: 32036576
[TBL] [Abstract][Full Text] [Related]
15. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma.
Abdelwahab MG; Fenton KE; Preul MC; Rho JM; Lynch A; Stafford P; Scheck AC
PLoS One; 2012; 7(5):e36197. PubMed ID: 22563484
[TBL] [Abstract][Full Text] [Related]
16. The ketogenic diet for the treatment of glioma: insights from genetic profiling.
Scheck AC; Abdelwahab MG; Fenton KE; Stafford P
Epilepsy Res; 2012 Jul; 100(3):327-37. PubMed ID: 22019313
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet.
Berrington A; Schreck KC; Barron BJ; Blair L; Lin DDM; Hartman AL; Kossoff E; Easter L; Whitlow CT; Jung Y; Hsu FC; Cervenka MC; Blakeley JO; Barker PB; Strowd RE
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1908-1915. PubMed ID: 31649157
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and glioma therapy.
Woolf EC; Scheck AC
CNS Oncol; 2012 Sep; 1(1):7-10. PubMed ID: 25054292
[No Abstract] [Full Text] [Related]
19. Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization.
Woodhouse C; Ward T; Gaskill-Shipley M; Chaudhary R
Curr Oncol; 2019 Aug; 26(4):e433-e438. PubMed ID: 31548811
[TBL] [Abstract][Full Text] [Related]
20. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production.
Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z
Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
